 | • レポートコード：MRC2-11QY04974 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は消退骨病のグローバル市場について調査・分析したレポートです。種類別（医学療法、放射線療法）市場規模、用途別（病院、診療所、診断センター、外来外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別消退骨病の競争状況、市場シェア ・世界の消退骨病市場：種類別市場規模 2015年-2020年（医学療法、放射線療法） ・世界の消退骨病市場：種類別市場規模予測 2021年-2026年（医学療法、放射線療法） ・世界の消退骨病市場：用途別市場規模 2015年-2020年（病院、診療所、診断センター、外来外科センター） ・世界の消退骨病市場：用途別市場規模予測 2021年-2026年（病院、診療所、診断センター、外来外科センター） ・北米の消退骨病市場分析：米国、カナダ ・ヨーロッパの消退骨病市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの消退骨病市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の消退骨病市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの消退骨病市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Varian Medical Systems、Elekta、BD、Merck、Sanofi、Roche、Novartis、Teleflex Incorporated、Vygon、Medtronic、Cook Medical、Smiths Medical、ATMOS MedizinTechnik ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Vanishing bone disease or Gorham-stout syndrome is a rare skeletal disease characterized by progressive osteolysis and the proliferation of lymphatic vessels within the bone which leads to the destruction and absorption of bone. Additionally, the bones affected by the disease are more prone to osteopenia and fracture.
The North American region dominates the global vanishing bone market due to the existing well-established healthcare system, increasing occurrences of rare diseases.
Market Analysis and Insights: Global Vanishing Bone Disease Market
The global Vanishing Bone Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Vanishing Bone Disease Scope and Market Size
Vanishing Bone Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Vanishing Bone Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Varian Medical Systems
Elekta
BD
Merck
Sanofi
Roche
Novartis
Teleflex Incorporated
Vygon
Medtronic
Cook Medical
Smiths Medical
ATMOS MedizinTechnik
Market segment by Type, the product can be split into
Medicine Therapy
Radiation Therapy
Market segment by Application, split into
Hospitals
Clinics
Diagnostic Centers
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Vanishing Bone Disease Revenue
1.4 Market by Type
1.4.1 Global Vanishing Bone Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Medicine Therapy
1.4.3 Radiation Therapy
1.5 Market by Application
1.5.1 Global Vanishing Bone Disease Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Diagnostic Centers
1.5.5 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Vanishing Bone Disease Market Perspective (2015-2026)
2.2 Global Vanishing Bone Disease Growth Trends by Regions
2.2.1 Vanishing Bone Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Vanishing Bone Disease Historic Market Share by Regions (2015-2020)
2.2.3 Vanishing Bone Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Vanishing Bone Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Vanishing Bone Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Vanishing Bone Disease Players by Market Size
3.1.1 Global Top Vanishing Bone Disease Players by Revenue (2015-2020)
3.1.2 Global Vanishing Bone Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Vanishing Bone Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Vanishing Bone Disease Market Concentration Ratio
3.2.1 Global Vanishing Bone Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Vanishing Bone Disease Revenue in 2019
3.3 Vanishing Bone Disease Key Players Head office and Area Served
3.4 Key Players Vanishing Bone Disease Product Solution and Service
3.5 Date of Enter into Vanishing Bone Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Vanishing Bone Disease Historic Market Size by Type (2015-2020)
4.2 Global Vanishing Bone Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Vanishing Bone Disease Market Size by Application (2015-2020)
5.2 Global Vanishing Bone Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Vanishing Bone Disease Market Size (2015-2020)
6.2 Vanishing Bone Disease Key Players in North America (2019-2020)
6.3 North America Vanishing Bone Disease Market Size by Type (2015-2020)
6.4 North America Vanishing Bone Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Vanishing Bone Disease Market Size (2015-2020)
7.2 Vanishing Bone Disease Key Players in Europe (2019-2020)
7.3 Europe Vanishing Bone Disease Market Size by Type (2015-2020)
7.4 Europe Vanishing Bone Disease Market Size by Application (2015-2020)
8 China
8.1 China Vanishing Bone Disease Market Size (2015-2020)
8.2 Vanishing Bone Disease Key Players in China (2019-2020)
8.3 China Vanishing Bone Disease Market Size by Type (2015-2020)
8.4 China Vanishing Bone Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Vanishing Bone Disease Market Size (2015-2020)
9.2 Vanishing Bone Disease Key Players in Japan (2019-2020)
9.3 Japan Vanishing Bone Disease Market Size by Type (2015-2020)
9.4 Japan Vanishing Bone Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Vanishing Bone Disease Market Size (2015-2020)
10.2 Vanishing Bone Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Vanishing Bone Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Vanishing Bone Disease Market Size by Application (2015-2020)
11 India
11.1 India Vanishing Bone Disease Market Size (2015-2020)
11.2 Vanishing Bone Disease Key Players in India (2019-2020)
11.3 India Vanishing Bone Disease Market Size by Type (2015-2020)
11.4 India Vanishing Bone Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Vanishing Bone Disease Market Size (2015-2020)
12.2 Vanishing Bone Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Vanishing Bone Disease Market Size by Type (2015-2020)
12.4 Central & South America Vanishing Bone Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Varian Medical Systems
13.1.1 Varian Medical Systems Company Details
13.1.2 Varian Medical Systems Business Overview
13.1.3 Varian Medical Systems Vanishing Bone Disease Introduction
13.1.4 Varian Medical Systems Revenue in Vanishing Bone Disease Business (2015-2020))
13.1.5 Varian Medical Systems Recent Development
13.2 Elekta
13.2.1 Elekta Company Details
13.2.2 Elekta Business Overview
13.2.3 Elekta Vanishing Bone Disease Introduction
13.2.4 Elekta Revenue in Vanishing Bone Disease Business (2015-2020)
13.2.5 Elekta Recent Development
13.3 BD
13.3.1 BD Company Details
13.3.2 BD Business Overview
13.3.3 BD Vanishing Bone Disease Introduction
13.3.4 BD Revenue in Vanishing Bone Disease Business (2015-2020)
13.3.5 BD Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Vanishing Bone Disease Introduction
13.4.4 Merck Revenue in Vanishing Bone Disease Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview
13.5.3 Sanofi Vanishing Bone Disease Introduction
13.5.4 Sanofi Revenue in Vanishing Bone Disease Business (2015-2020)
13.5.5 Sanofi Recent Development
13.6 Roche
13.6.1 Roche Company Details
13.6.2 Roche Business Overview
13.6.3 Roche Vanishing Bone Disease Introduction
13.6.4 Roche Revenue in Vanishing Bone Disease Business (2015-2020)
13.6.5 Roche Recent Development
13.7 Novartis
13.7.1 Novartis Company Details
13.7.2 Novartis Business Overview
13.7.3 Novartis Vanishing Bone Disease Introduction
13.7.4 Novartis Revenue in Vanishing Bone Disease Business (2015-2020)
13.7.5 Novartis Recent Development
13.8 Teleflex Incorporated
13.8.1 Teleflex Incorporated Company Details
13.8.2 Teleflex Incorporated Business Overview
13.8.3 Teleflex Incorporated Vanishing Bone Disease Introduction
13.8.4 Teleflex Incorporated Revenue in Vanishing Bone Disease Business (2015-2020)
13.8.5 Teleflex Incorporated Recent Development
13.9 Vygon
13.9.1 Vygon Company Details
13.9.2 Vygon Business Overview
13.9.3 Vygon Vanishing Bone Disease Introduction
13.9.4 Vygon Revenue in Vanishing Bone Disease Business (2015-2020)
13.9.5 Vygon Recent Development
13.10 Medtronic
13.10.1 Medtronic Company Details
13.10.2 Medtronic Business Overview
13.10.3 Medtronic Vanishing Bone Disease Introduction
13.10.4 Medtronic Revenue in Vanishing Bone Disease Business (2015-2020)
13.10.5 Medtronic Recent Development
13.11 Cook Medical
10.11.1 Cook Medical Company Details
10.11.2 Cook Medical Business Overview
10.11.3 Cook Medical Vanishing Bone Disease Introduction
10.11.4 Cook Medical Revenue in Vanishing Bone Disease Business (2015-2020)
10.11.5 Cook Medical Recent Development
13.12 Smiths Medical
10.12.1 Smiths Medical Company Details
10.12.2 Smiths Medical Business Overview
10.12.3 Smiths Medical Vanishing Bone Disease Introduction
10.12.4 Smiths Medical Revenue in Vanishing Bone Disease Business (2015-2020)
10.12.5 Smiths Medical Recent Development
13.13 ATMOS MedizinTechnik
10.13.1 ATMOS MedizinTechnik Company Details
10.13.2 ATMOS MedizinTechnik Business Overview
10.13.3 ATMOS MedizinTechnik Vanishing Bone Disease Introduction
10.13.4 ATMOS MedizinTechnik Revenue in Vanishing Bone Disease Business (2015-2020)
10.13.5 ATMOS MedizinTechnik Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Vanishing Bone Disease Key Market Segments
Table 2. Key Players Covered: Ranking by Vanishing Bone Disease Revenue
Table 3. Ranking of Global Top Vanishing Bone Disease Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Vanishing Bone Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Medicine Therapy
Table 6. Key Players of Radiation Therapy
Table 7. Global Vanishing Bone Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Vanishing Bone Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Vanishing Bone Disease Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Vanishing Bone Disease Market Share by Regions (2015-2020)
Table 11. Global Vanishing Bone Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Vanishing Bone Disease Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Vanishing Bone Disease Market Growth Strategy
Table 17. Main Points Interviewed from Key Vanishing Bone Disease Players
Table 18. Global Vanishing Bone Disease Revenue by Players (2015-2020) (Million US$)
Table 19. Global Vanishing Bone Disease Market Share by Players (2015-2020)
Table 20. Global Top Vanishing Bone Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vanishing Bone Disease as of 2019)
Table 21. Global Vanishing Bone Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Vanishing Bone Disease Product Solution and Service
Table 24. Date of Enter into Vanishing Bone Disease Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Vanishing Bone Disease Market Size by Type (2015-2020) (Million US$)
Table 27. Global Vanishing Bone Disease Market Size Share by Type (2015-2020)
Table 28. Global Vanishing Bone Disease Revenue Market Share by Type (2021-2026)
Table 29. Global Vanishing Bone Disease Market Size Share by Application (2015-2020)
Table 30. Global Vanishing Bone Disease Market Size by Application (2015-2020) (Million US$)
Table 31. Global Vanishing Bone Disease Market Size Share by Application (2021-2026)
Table 32. North America Key Players Vanishing Bone Disease Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Vanishing Bone Disease Market Share (2019-2020)
Table 34. North America Vanishing Bone Disease Market Size by Type (2015-2020) (Million US$)
Table 35. North America Vanishing Bone Disease Market Share by Type (2015-2020)
Table 36. North America Vanishing Bone Disease Market Size by Application (2015-2020) (Million US$)
Table 37. North America Vanishing Bone Disease Market Share by Application (2015-2020)
Table 38. Europe Key Players Vanishing Bone Disease Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Vanishing Bone Disease Market Share (2019-2020)
Table 40. Europe Vanishing Bone Disease Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Vanishing Bone Disease Market Share by Type (2015-2020)
Table 42. Europe Vanishing Bone Disease Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Vanishing Bone Disease Market Share by Application (2015-2020)
Table 44. China Key Players Vanishing Bone Disease Revenue (2019-2020) (Million US$)
Table 45. China Key Players Vanishing Bone Disease Market Share (2019-2020)
Table 46. China Vanishing Bone Disease Market Size by Type (2015-2020) (Million US$)
Table 47. China Vanishing Bone Disease Market Share by Type (2015-2020)
Table 48. China Vanishing Bone Disease Market Size by Application (2015-2020) (Million US$)
Table 49. China Vanishing Bone Disease Market Share by Application (2015-2020)
Table 50. Japan Key Players Vanishing Bone Disease Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Vanishing Bone Disease Market Share (2019-2020)
Table 52. Japan Vanishing Bone Disease Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Vanishing Bone Disease Market Share by Type (2015-2020)
Table 54. Japan Vanishing Bone Disease Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Vanishing Bone Disease Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Vanishing Bone Disease Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Vanishing Bone Disease Market Share (2019-2020)
Table 58. Southeast Asia Vanishing Bone Disease Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Vanishing Bone Disease Market Share by Type (2015-2020)
Table 60. Southeast Asia Vanishing Bone Disease Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Vanishing Bone Disease Market Share by Application (2015-2020)
Table 62. India Key Players Vanishing Bone Disease Revenue (2019-2020) (Million US$)
Table 63. India Key Players Vanishing Bone Disease Market Share (2019-2020)
Table 64. India Vanishing Bone Disease Market Size by Type (2015-2020) (Million US$)
Table 65. India Vanishing Bone Disease Market Share by Type (2015-2020)
Table 66. India Vanishing Bone Disease Market Size by Application (2015-2020) (Million US$)
Table 67. India Vanishing Bone Disease Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Vanishing Bone Disease Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Vanishing Bone Disease Market Share (2019-2020)
Table 70. Central & South America Vanishing Bone Disease Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Vanishing Bone Disease Market Share by Type (2015-2020)
Table 72. Central & South America Vanishing Bone Disease Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Vanishing Bone Disease Market Share by Application (2015-2020)
Table 74. Varian Medical Systems Company Details
Table 75. Varian Medical Systems Business Overview
Table 76. Varian Medical Systems Product
Table 77. Varian Medical Systems Revenue in Vanishing Bone Disease Business (2015-2020) (Million US$)
Table 78. Varian Medical Systems Recent Development
Table 79. Elekta Company Details
Table 80. Elekta Business Overview
Table 81. Elekta Product
Table 82. Elekta Revenue in Vanishing Bone Disease Business (2015-2020) (Million US$)
Table 83. Elekta Recent Development
Table 84. BD Company Details
Table 85. BD Business Overview
Table 86. BD Product
Table 87. BD Revenue in Vanishing Bone Disease Business (2015-2020) (Million US$)
Table 88. BD Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Product
Table 92. Merck Revenue in Vanishing Bone Disease Business (2015-2020) (Million US$)
Table 93. Merck Recent Development
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Product
Table 97. Sanofi Revenue in Vanishing Bone Disease Business (2015-2020) (Million US$)
Table 98. Sanofi Recent Development
Table 99. Roche Company Details
Table 100. Roche Business Overview
Table 101. Roche Product
Table 102. Roche Revenue in Vanishing Bone Disease Business (2015-2020) (Million US$)
Table 103. Roche Recent Development
Table 104. Novartis Company Details
Table 105. Novartis Business Overview
Table 106. Novartis Product
Table 107. Novartis Revenue in Vanishing Bone Disease Business (2015-2020) (Million US$)
Table 108. Novartis Recent Development
Table 109. Teleflex Incorporated Business Overview
Table 110. Teleflex Incorporated Product
Table 111. Teleflex Incorporated Company Details
Table 112. Teleflex Incorporated Revenue in Vanishing Bone Disease Business (2015-2020) (Million US$)
Table 113. Teleflex Incorporated Recent Development
Table 114. Vygon Company Details
Table 115. Vygon Business Overview
Table 116. Vygon Product
Table 117. Vygon Revenue in Vanishing Bone Disease Business (2015-2020) (Million US$)
Table 118. Vygon Recent Development
Table 119. Medtronic Company Details
Table 120. Medtronic Business Overview
Table 121. Medtronic Product
Table 122. Medtronic Revenue in Vanishing Bone Disease Business (2015-2020) (Million US$)
Table 123. Medtronic Recent Development
Table 124. Cook Medical Company Details
Table 125. Cook Medical Business Overview
Table 126. Cook Medical Product
Table 127. Cook Medical Revenue in Vanishing Bone Disease Business (2015-2020) (Million US$)
Table 128. Cook Medical Recent Development
Table 129. Smiths Medical Company Details
Table 130. Smiths Medical Business Overview
Table 131. Smiths Medical Product
Table 132. Smiths Medical Revenue in Vanishing Bone Disease Business (2015-2020) (Million US$)
Table 133. Smiths Medical Recent Development
Table 134. ATMOS MedizinTechnik Company Details
Table 135. ATMOS MedizinTechnik Business Overview
Table 136. ATMOS MedizinTechnik Product
Table 137. ATMOS MedizinTechnik Revenue in Vanishing Bone Disease Business (2015-2020) (Million US$)
Table 138. ATMOS MedizinTechnik Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vanishing Bone Disease Market Share by Type: 2020 VS 2026
Figure 2. Medicine Therapy Features
Figure 3. Radiation Therapy Features
Figure 4. Global Vanishing Bone Disease Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Vanishing Bone Disease Report Years Considered
Figure 10. Global Vanishing Bone Disease Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Vanishing Bone Disease Market Share by Regions: 2020 VS 2026
Figure 12. Global Vanishing Bone Disease Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Vanishing Bone Disease Market Share by Players in 2019
Figure 15. Global Top Vanishing Bone Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vanishing Bone Disease as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Vanishing Bone Disease Revenue in 2019
Figure 17. North America Vanishing Bone Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Vanishing Bone Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Vanishing Bone Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Vanishing Bone Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Vanishing Bone Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Vanishing Bone Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Vanishing Bone Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
骨転移治療薬の世界市場（～2026年） Bone metastasis is the third most common condition in metastatic cancers and occurs in 60-65% of patients with metastatic cancers. The spine is the most common site of bone metastasis. Other common sites include ribs, skull, pelvis (hip bone), femur (leg bone) and humerus (arm bone). Bone metastatic…- 歯科用骨代替品・生体材料の世界市場（～2026年） Dental bone grafts substitutes and biomaterials are regenerative products which are used as a filler support to facilitate dental bone formation and accelerate wound healing. These dental grafts are bioresorbable or biocompatible with no antigen-antibody reaction. These dental bone substitutes assis…
- 骨・ミネラル診断検査の世界市場（～2026年） Bone and mineral metabolism disorder is a collective term used to describe various conditions that make bones weak. Bone mineral metabolism maintains sufficient concentration of inorganic ions in blood serum. Progressive chronic kidney disease, especially end-stage renal disease (ESRD), is responsib…
- 骨肉腫診断・治療の世界市場（～2026年） Bone cancer is a malignant tumor that arises from the cells that make up the bones of the body. Robust healthcare expenditure in developed countries, genetic disorder, and development of stem cell transplant technology are some of the major factors that drive the growth of the market. Rising geriatr…
- 歯科用骨移植代替品・その他生体材料の世界市場（～2026年） Bone graft substitution is a type of medical procedure that can help a patient replace a missing tooth. The procedure can also be used to add more bone to a support dental implant, enabling it to develop faster and better. The global dental bone graft substitutes and other biomaterials market thus p…